Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Assura plc ( (GB:AGR) ).
Assura plc has announced the issuance of 5,784,304 new ordinary shares to its Employee Benefit Trust, as part of its Performance Share Plan. These shares are set to be listed on the London Stock Exchange, increasing the total number of Assura’s ordinary shares in issue to 3,256,393,191. This move is expected to enhance the company’s share liquidity and provide additional voting rights, reflecting Assura’s ongoing commitment to employee incentives and shareholder engagement.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Spark’s Take on GB:AGR Stock
According to Spark, TipRanks’ AI Analyst, GB:AGR is a Outperform.
Assura plc scores well due to its strong cash flow and technical indicators, alongside strategic corporate actions that enhance investor confidence. However, the company faces profitability challenges with recurring net losses, slightly offset by a strong dividend yield. Focus on improving operational efficiencies and leveraging its strong asset base could bolster future performance.
To see Spark’s full report on GB:AGR stock, click here.
More about Assura plc
Assura plc operates in the healthcare real estate sector, focusing on the development and management of primary care properties across the UK. The company is known for providing modern, purpose-built healthcare facilities, catering primarily to the needs of the National Health Service (NHS) and other healthcare providers.
Average Trading Volume: 23,241,259
Technical Sentiment Signal: Buy
Current Market Cap: £1.63B
For detailed information about AGR stock, go to TipRanks’ Stock Analysis page.